Search

Your search keyword '"Mojal, Sergi"' showing total 255 results

Search Constraints

Start Over You searched for: Author "Mojal, Sergi" Remove constraint Author: "Mojal, Sergi"
255 results on '"Mojal, Sergi"'

Search Results

5. Supplementary Information to Gal-1 expression analysis in the GLIOCAT multicenter study: role as a prognostic factor and an immune-suppressive biomarker

6. Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker

11. Supplementary Figure 3 from Targeting Epithelial-to-Mesenchymal Transition with Met Inhibitors Reverts Chemoresistance in Small Cell Lung Cancer

12. Supplementary Figure 6 from Targeting Epithelial-to-Mesenchymal Transition with Met Inhibitors Reverts Chemoresistance in Small Cell Lung Cancer

13. Supplementary Figure 2 from Targeting Epithelial-to-Mesenchymal Transition with Met Inhibitors Reverts Chemoresistance in Small Cell Lung Cancer

14. Supplementary Methods, Figure Legend, Tables 1 - 6 from Targeting Epithelial-to-Mesenchymal Transition with Met Inhibitors Reverts Chemoresistance in Small Cell Lung Cancer

15. Supplementary Figure 1 from Targeting Epithelial-to-Mesenchymal Transition with Met Inhibitors Reverts Chemoresistance in Small Cell Lung Cancer

16. Supplementary Figure 5 from Targeting Epithelial-to-Mesenchymal Transition with Met Inhibitors Reverts Chemoresistance in Small Cell Lung Cancer

17. Supplementary Figure 7 from Targeting Epithelial-to-Mesenchymal Transition with Met Inhibitors Reverts Chemoresistance in Small Cell Lung Cancer

18. Supplementary Figure 4 from Targeting Epithelial-to-Mesenchymal Transition with Met Inhibitors Reverts Chemoresistance in Small Cell Lung Cancer

19. Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker

34. A validated clinical-genetic score for assessing the risk of thrombosis in patients with COVID-19 receiving thromboprophylaxis

36. TMAO and Gut Microbial-Derived Metabolites TML and γBB Are Not Associated with Thrombotic Risk in Patients with Venous Thromboembolism

39. Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease

40. Relationship between consumption of MRSA-active antibiotics and burden of MRSA in acute care hospitals in Catalonia, Spain

43. Impact of pre-admission antithrombotic therapy on disease severity and mortality in patients hospitalized for COVID-19

48. Cervista HPV HR Test for Cervical Cancer Screening: A Comparative Study in the Catalonian Population

49. Complementary value of electron microscopy and immunohistochemistry in the diagnosis of non-small cell lung cancer: A potential role for electron microscopy in the era of targeted therapy

50. Prognostic value of VEGFR2 immunoexpression in glioblastoma

Catalog

Books, media, physical & digital resources